jetcityimage
- An analysis of an ongoing study indicates that there may be synergies in improving both psoriasis and metabolic benefits when Eli Lilly’s (LLY) Taltz (ixekizumab) is used along with Zepbound (tirzepatide).
- An exploratory analysis of the phase 3b TOGETHER-PsO trial